Great read! Was wondering what your thoughts were on the strategic rationale for payers in regards to potential M&A with telehealth providers like Teladongo/MDLive/Amwell? Would it be because payers building out their own telehealth platform would be too costly/take too much time? Or is it more of a play to have access to the millions of patients already 'aligned' with Teladongo?
Great read! Was wondering what your thoughts were on the strategic rationale for payers in regards to potential M&A with telehealth providers like Teladongo/MDLive/Amwell? Would it be because payers building out their own telehealth platform would be too costly/take too much time? Or is it more of a play to have access to the millions of patients already 'aligned' with Teladongo?